We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current DIA market cap is 2.45B. The company's latest EPS is EUR 6.7964 and P/E is 15.87.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 706.32M | 881.31M | 1.24B | 1.36B | 1.15B |
| Operating Income | 218.98M | 326.31M | 423.63M | 365.68M | 214.6M |
| Net Income | 175.74M | 247.87M | 310.97M | 240.91M | 159.85M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 1.06B | 1.25B | 3.23B | 3.41B | 3.21B |
| Total Liabilities | 214.93M | 290.13M | 1.86B | 1.89B | 1.67B |
| Total Equity | 848.62M | 956.32M | 1.37B | 1.52B | 1.54B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 232.67M | 304.56M | 400.66M | 389.34M | 311.66M |
| Investing | -52.22M | -73.02M | -1.61B | -231.95M | -29.1M |
| Financing | -96.39M | -40.89M | 1.26B | -333.04M | -235.96M |
| Market Cap | 2.45B |
| Price to Earnings Ratio | 15.87 |
| Price to Sales Ratio | 2.21 |
| Price to Cash Ratio | 9.05 |
| Price to Book Ratio | 1.65 |
| Dividend Yield | 1.10% |
| Shares Outstanding | 23.52M |
| Average Volume (1 week) | 76.79k |
| Average Volume (1 Month) | 128.66k |
| 52 Week Change | 20.27% |
| 52 Week High | 112.35 |
| 52 Week Low | 82.72 |
| Spread (Intraday) | 1.15 (1.1%) |
| Company Name | DiaSorin SPA |
| Address |
via crescentino snc 13040 piacenza, piacenza 13040 |
| Website | https://www.diasorin.com |
| Industry | in vitro,in vivo diagnostics (2835) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
